Skip to main content

J-Pharma Co.,Ltd.

ジェイファーマ株式会社

Valuation

Fundamental ratios for the latest reported period.

Ticker: 520A
FY2025 · 2026-03-31
Gross margin
Operating margin
Net margin
Return on equity
Return on assets-51.8%
Revenue growth (YoY)
EPS (basic)¥-195.08
EPS growth (YoY)
Current ratio12.57x
Equity ratio85.4%
Book value / share¥226.07
Free cash flow-2,253 M